Back to the archive

The encyclopedia · Product & Design · Product decision · 2017–2025

Xinba's own sanitary-pad brand tested positive for a carcinogen — he quit streaming

Consumer testing found carcinogenic thiourea in batches of Mianmima, the pad brand Xinba founded. The brand insisted all was fine; he exited streaming.

Guangdong Mianmima Health Technology (广东棉密码健康科技) · 2025-08-18

What happened

Mianmima was a sanitary pad brand Xinba founded in 2017 and sold above all through his own streams, marketed around a tea-polyphenol 'antioxidant chip' and claimed to have tens of millions of users. It had an earlier life as ZUZU, sold through WeChat commerce with his wife Chu Ruixue as its face. In Xin Xuan's ¥50 billion sales year of 2023, it was one of the in-house blockbusters.

In July 2025 reports from consumer-organized group testing surfaced: batches of Mianmima pads produced between September 2019 and January 2025 had tested positive for very high levels of thiourea, a recognized carcinogen. Hundreds of consumers reported health problems after use, and more than 30 users publicly said they had developed thyroid cancer, several with years of purchase records. On July 24 the brand answered with a statement: products 'assessed as risk-free', sampling inspections passed. The Paper noted that the May test report the company brandished contained no thiourea figure.

On the evening of August 18, 2025, during Xin Xuan's '818' anniversary stream, Xinba announced his exit from livestreaming, citing health reasons — without once addressing the Mianmima controversy. His wife Chu Ruixue took over Xin Xuan Group; it was his fifth announcement of walking away. He left behind a record that includes the sugar-water bird's nest affair, which ended in refunds-plus-triple-compensation of more than ¥79.7 million, and a ¥1.75 million false-advertising fine in January 2025.

Why it happened

  • A streamer's own brand collapses the distance between marketing and quality control — the founder vouched for every batch personally, so every batch was on his record.
  • The answer to carcinogen findings was denial: 'assessed as risk-free', backed by a test report that did not test for thiourea.
  • The founder exited without addressing the scandal, converting a product-safety crisis into a referendum on the streamer-brand model.
What it costCarcinogen findings; founder quit streamingcostly

The lesson

When a streamer's own brand is the product, trust is the quality system — and one batch of test results can void it. Walking away mid-scandal converts a product crisis into a verdict on the model.

Aftermath

Xin Xuan and Mianmima maintain the products are compliant and deny any carcinogenic risk; consumers seeking remedies face burden-of-proof difficulties. Chu Ruixue runs Xin Xuan, and the group's streams continue. The brand's July 24 statement remains its only substantive answer to the testing reports.

Sources

spotted an error? The club wants to know.

Comments · 0

    Sign in to join the comments.

    More like this

    Somewhere, someone solved the problem this company failed at. 2nd Opinion →